Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
28,93 USD | +1,58% | +2,05% | +26,17% |
Omzet 2024 * | 208 mln. 192 mln. | Omzet 2025 * | 120 mln. 111 mln. | Marktkapitalisatie | 1,69 mld. 1,56 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 24 mln. 22,23 mln. | Nettowinst (verlies) 2025 * | -6 mln. -5,56 mln. | EV/omzet 2024 * | 6,26 x |
Nettoliquiditeiten 2024 * | 388 mln. 359 mln. | Nettoliquiditeiten 2025 * | 637 mln. 590 mln. | EV/omzet 2025 * | 8,75 x |
K/w-verhouding 2024 * |
79,7
x | K/w-verhouding 2025 * |
-35,7
x | Werknemers | 112 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,48% |
Recentste transcriptie over Protagonist Therapeutics, Inc.
1 dag | +1,58% | ||
1 week | +2,05% | ||
Lopende maand | -4,77% | ||
1 maand | -4,93% | ||
3 maanden | +25,08% | ||
6 maanden | +68,88% | ||
Lopend jaar | +26,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18-04-22 |
Chief Tech/Sci/R&D Officer | - | 01-07-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08-06-17 |
Harold Selick
CHM | Chairman | 69 | 01-02-09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26-10-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0,00% | - | |
0.04% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 28,93 | +1,58% | 653 366 |
27-03-24 | 28,48 | +1,71% | 359 436 |
26-03-24 | 28 | +0,39% | 307 470 |
25-03-24 | 27,89 | -0,50% | 247 394 |
22-03-24 | 28,03 | -1,13% | 376 485 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,17% | 1,69 mld. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
-8,77% | 11,06 mld. |